Feitong Lei
Overview
Explore the profile of Feitong Lei including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
60
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lei F, Sekkath-Veedu J, Huang B, Chen Q, Shah-Jadeja M, Stinchcombe T, et al.
Clin Lung Cancer
. 2024 Nov;
26(1):e81-e90.
PMID: 39550246
Introduction: Stage IIIA non-small cell lung cancers (NSCLC) are treated with surgery-based multimodality approach or definitive chemoradiation therapy plus durvalumab consolidation. It is not clear whether surgery-based multimodality therapy has...
2.
Burus T, Lei F, Huang B, Christian W, Hull P, Ellis A, et al.
JAMA Netw Open
. 2024 Sep;
7(9):e2432288.
PMID: 39240562
Importance: US cancer diagnoses were substantially lower than expected during the COVID-19 pandemic in 2020. A national study on the extent to which rates recovered in 2021 has not yet...
3.
Hammerslag L, Talbert J, Slavova S, Lei F, Freeman P, Marks K, et al.
J Subst Use Addict Treat
. 2024 May;
164:209391.
PMID: 38740189
Introduction: Long-acting injectable buprenorphine (LAI-bup) formulations have advantages over transmucosal buprenorphine (TM-bup), but barriers may limit their utilization. Several policies shifted during the COVID-19 pandemic to promote buprenorphine access. The...
4.
Lei F, Lofwall M, McAninch J, Adatorwovor R, Slade E, Freeman P, et al.
J Addict Med
. 2024 Apr;
18(3):319-326.
PMID: 38598300
Objective: Buprenorphine is a medication for opioid use disorder that reduces mortality. This study aims to investigate the less well-understood relationship between the dose in the early stages of treatment...
5.
Burus T, Lei F, Huang B, Christian W, Hull P, Ellis A, et al.
JAMA Oncol
. 2024 Feb;
10(4):500-507.
PMID: 38386344
Importance: The COVID-19 pandemic disrupted the normal course of cancer screening and detection in the US. A nationwide analysis of the extent of this disruption using cancer registry data has...
6.
Trott S, Lei F, Christian W, Mao X, Lehmkuhl B, Kejner A
Cancer Causes Control
. 2024 Jan;
35(5):817-824.
PMID: 38212533
Purpose: Populations with high cancer risk that are targeted for screening, education, and vaccination have been shown to increase rates of screening, which ultimately may improve timing of diagnosis and...
7.
Marks K, Oyler D, Strickland J, Jaggers J, Roberts M, Miracle D, et al.
Harm Reduct J
. 2023 Nov;
20(1):171.
PMID: 38017424
Background: Bystander administration of naloxone is a critical strategy to mitigate opioid overdose mortality. To ensure bystanders' willingness to carry and administer naloxone in response to a suspected overdose, it...
8.
Lei F, Vanderpool R, McLouth L, Romond E, Chen Q, Durbin E, et al.
Cancer
. 2023 Apr;
129(12):1821-1835.
PMID: 37063057
Background: Depression is common among breast cancer patients and can affect concordance with guideline-recommended treatment plans. Yet, the impact of depression on cancer treatment and survival is understudied, particularly in...
9.
Leachman J, Heier K, Lei F, Ahmed N, Dalmasso C, Duncan M, et al.
Biol Sex Differ
. 2022 Jun;
13(1):29.
PMID: 35706066
Background: Adverse childhood experiences (ACEs) are an independent risk factor for chronic diseases, including type 2 diabetes, stroke and ischemic heart disease. However, the effect of ACEs considering sex and...
10.
Lei F, Lofwall M, Freeman P, Slade E, Vickers-Smith R, Slavova S
J Rural Health
. 2022 May;
39(1):186-196.
PMID: 35610181
Purpose: With surging opioid-involved overdoses, maintaining access to opioid use disorder (OUD) treatment is critical during the COVID-19 pandemic. We examined changes in transmucosal buprenorphine prescribing for OUD treatment in...